Correlation Between Microsoft Corp and Cardiol Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Microsoft Corp and Cardiol Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft Corp and Cardiol Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft Corp CDR and Cardiol Therapeutics Class, you can compare the effects of market volatilities on Microsoft Corp and Cardiol Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft Corp with a short position of Cardiol Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft Corp and Cardiol Therapeutics.

Diversification Opportunities for Microsoft Corp and Cardiol Therapeutics

0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between Microsoft and Cardiol is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft Corp CDR and Cardiol Therapeutics Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiol Therapeutics and Microsoft Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft Corp CDR are associated (or correlated) with Cardiol Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiol Therapeutics has no effect on the direction of Microsoft Corp i.e., Microsoft Corp and Cardiol Therapeutics go up and down completely randomly.

Pair Corralation between Microsoft Corp and Cardiol Therapeutics

Assuming the 90 days trading horizon Microsoft Corp CDR is expected to generate 0.34 times more return on investment than Cardiol Therapeutics. However, Microsoft Corp CDR is 2.91 times less risky than Cardiol Therapeutics. It trades about 0.39 of its potential returns per unit of risk. Cardiol Therapeutics Class is currently generating about 0.1 per unit of risk. If you would invest  2,601  in Microsoft Corp CDR on April 21, 2025 and sell it today you would earn a total of  1,074  from holding Microsoft Corp CDR or generate 41.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Microsoft Corp CDR  vs.  Cardiol Therapeutics Class

 Performance 
       Timeline  
Microsoft Corp CDR 

Risk-Adjusted Performance

Strong

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Microsoft Corp CDR are ranked lower than 30 (%) of all global equities and portfolios over the last 90 days. In spite of rather abnormal technical and fundamental indicators, Microsoft Corp exhibited solid returns over the last few months and may actually be approaching a breakup point.
Cardiol Therapeutics 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cardiol Therapeutics Class are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Cardiol Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Microsoft Corp and Cardiol Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Microsoft Corp and Cardiol Therapeutics

The main advantage of trading using opposite Microsoft Corp and Cardiol Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft Corp position performs unexpectedly, Cardiol Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will offset losses from the drop in Cardiol Therapeutics' long position.
The idea behind Microsoft Corp CDR and Cardiol Therapeutics Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Stocks Directory
Find actively traded stocks across global markets